FDA Takes Steps to Curb Opioid Misuse and Abuse

Manufacturers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drug, including education on safe prescribing practices and non-opioid alternatives, including principles related to the acute and chronic pain management; non-pharmacologic treatments for pain; and pharmacologic treatments for pain (both non-opioid analgesic and opioid analgesic).  For the first time, this training will also be made available to other healthcare professionals who are involved in the management of patients with pain, including pharmacists and nurses, which is in addition to prescribers of opioid analgesics.

https://blogs.fda.gov/fdavoice/index.php/2017/09/fda-takes-important-steps-to-st...